Controversial Alzheimer's Drug Behind About Half of Medicare's Yearly Price Bump
Aduhelm, approved by the FDA in June despite much pushback, is expected to be a huge burden on the health care system.
Source: truthout.org
Stay updated with breaking news from Matthewe Shepard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aduhelm, approved by the FDA in June despite much pushback, is expected to be a huge burden on the health care system.